{
    "Symbol": "NVO",
    "AssetType": "Common Stock",
    "Name": "Novo Nordisk A/S",
    "Description": "Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.",
    "CIK": "353278",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "NOVO ALLE DK 2880, BAGSVAERD DENMARK, DK",
    "OfficialSite": "https://www.novonordisk.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "512364249000",
    "EBITDA": "126561001000",
    "PERatio": "39.79",
    "PEGRatio": "1.8",
    "BookValue": "25.24",
    "DividendPerShare": "9.9",
    "DividendYield": "0.0123",
    "EPS": "2.96",
    "RevenuePerShareTTM": "57.8",
    "ProfitMargin": "0.348",
    "OperatingMarginTTM": "0.465",
    "ReturnOnAssetsTTM": "0.228",
    "ReturnOnEquityTTM": "0.886",
    "RevenueTTM": "258002993000",
    "GrossProfitTTM": "148506000000",
    "DilutedEPSTTM": "2.96",
    "QuarterlyEarningsGrowthYOY": "0.039",
    "QuarterlyRevenueGrowthYOY": "0.253",
    "AnalystTargetPrice": "142.62",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "7",
    "AnalystRatingHold": "1",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "39.79",
    "ForwardPE": "29.33",
    "PriceToSalesRatioTTM": "1.986",
    "PriceToBookRatio": "31.64",
    "EVToRevenue": "13.84",
    "EVToEBITDA": "26.66",
    "Beta": "0.148",
    "52WeekHigh": "147.59",
    "52WeekLow": "91.93",
    "50DayMovingAverage": "130.16",
    "200DayMovingAverage": "127.24",
    "SharesOutstanding": "3376130000",
    "DividendDate": "2024-08-26",
    "ExDividendDate": "2024-08-16"
}